[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100620056":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":22,"centralContacts":25,"locations":31,"responsibleParty":44,"collaborators":48,"id":51,"slug":22,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":58,"maxAge":22,"enrollmentInfo":59,"targetDuration":22,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":22,"overallStatus":69,"whyStopped":22,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Beth Israel Deaconess Medical Center","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Guideline-based Care","ACTIVE_COMPARATOR","Remote monitoring programming scheduled for alert transmissions, patient-initiated transmissions, and routine transmissions (scheduled to occur every 90 days from the date of enrollment in the study); in-office interrogations on at least an annual basis",[13],"Other: Guideline-based Care",{"label":15,"type":10,"description":16,"interventionNames":17},"Alert-based care","Alert-based care is an alternative strategy for longitudinal management of patients with wireless pacemakers and implantable defibrillators",[18],"Other: Alert-based care",[20,23],{"type":6,"name":15,"description":16,"armGroupLabels":21,"otherNames":22},[15],null,{"type":6,"name":9,"description":11,"armGroupLabels":24,"otherNames":22},[9],[26],{"name":27,"role":28,"phone":29,"phoneExt":22,"email":30},"Daniel B Kramer, MD, MPH","CONTACT","617-667-8800","dkramer@bidmc.harvard.edu",[32],{"facility":5,"status":22,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":22},"Boston","Massachusetts","02215","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-71.05977,42.35843,{"lat":42,"lon":41},{"type":45,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":22,"oldOrganization":22},"PRINCIPAL_INVESTIGATOR","Daniel B. Kramer","Associate Professor of Medicine",[49],{"name":50,"class":6},"Patient-Centered Outcomes Research Institute","100620056",false,"NCT07352657","Remote Alert Pathway To Optimize CaRe of Cardiac Implantable Electrical Devices: The RAPTOR-CIED Study (Main Phase)","RAPTOR - MAIN","Inclusion Criteria:\n\n1. Adult aged \\> 18 years\n2. Clinically stable by investigator assessment\n3. Has a newly implanted or existing wireless CIED: single, dual-chamber, biventricular, subcutaneous\u002Fextravascular, and leadless systems are all eligible, including pacemakers or implantable cardioverter-defibrillators (ICDs)\n4. CIED is from one of the 4 major CIED manufacturers in the US market (99% of implants in the US): Medtronic, Boston Scientific, Abbott, Biotronik\n5. Currently enrolled in remote monitoring as part of standard of care\n6. Primary clinical electrophysiology follow-up at the enrolling center\n7. Understands spoken and written English, Spanish, or Portuguese\n8. Has sufficient cognitive function to answer standardized questions about study rationale and procedures.\n\nExclusion Criteria:\n\n1. Presence of insertable cardiac monitor, either in isolation or in combination with any other CIED\n2. Listed for cardiac transplantation prior to enrollment (N.B. if a patient becomes listed for transplantation during the study, they may continue study participation)\n3. Participation in another study related to novel CIED technology or remote monitoring.","ALL","18 Years",{"count":60,"type":61},3000,"ESTIMATED","INTERVENTIONAL",[64],"NA","he Remote Alert Pathway to Optimize Care of Cardiac Implantable Electrical Devices (RAPTOR-CIED) Study is a pragmatic, multi-center, randomized trial with 1:1 patient-level randomization comparing the safety and effectiveness of alert-driven care versus guideline-based care for patients with wireless cardiac implantable electrical devices (CIEDs).\n\nThe study will be conducted in 2 phases: a Feasibility Phase and a Main Phase. This registration outlines the goals and design features of the Main Phase of the study.",[67,68],"Pacemaker","Implantable Defibrillator","NOT_YET_RECRUITING","2026-02-04",{"date":72,"type":73},"2026-02-06","ACTUAL",{"date":75,"type":61},"2026-12-01",{"date":77,"type":61},"2031-01-31",{"name":5,"class":6},1]